Intensive care medicine
The most recent articles from:
Intensive Care Med
-
Intensive care medicine · May 2007
Retracted PublicationGlycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut.
This study investigated the effects of TDZD-8, a potent and selective GSK-3beta inhibitor, on tissue injury caused by ischaemia/reperfusion (I/R) of the gut. ⋯ Based on these findings we propose that TDZD-8 would be useful in the treatment of various ischaemia and reperfusion diseases.